Genflow Biosciences plc (LON:GENF)

London flag London · Delayed Price · Currency is GBP · Price in GBX
1.850
-0.025 (-1.33%)
Mar 6, 2026, 4:35 PM GMT
5.71%
Market Cap 9.13M
Revenue (ttm) n/a
Net Income (ttm) -1.80M
Shares Out 493.55M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 467,012
Average Volume 3,316,692
Open 1.895
Previous Close 1.875
Day's Range 1.850 - 1.900
52-Week Range 0.550 - 2.700
Beta 2.24
RSI 46.37
Earnings Date May 6, 2026

About Genflow Biosciences

Genflow Biosciences plc, together with its subsidiaries, engages in the research and development of gene therapy targeting the upstream biology of aging in the United Kingdom and Belgium. The company operates as a pre-clinical biotechnology company that focuses on developing biological interventions aimed at tackling the effects of aging, slowing, and halting the aging process, as well as reducing the incidence of age-related diseases. Its lead drug candidate is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for in... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2020
Employees 5
Stock Exchange London Stock Exchange
Ticker Symbol GENF
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.